Fortrea
FTRE20.4001.45% ( -0.300 )
Fortrea (FTRE)
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechn...
- Open
- 19.590
- High
- 21.390
- Low
- 19.500
- Prev. Close
- 20.700
- Volume
- 3.16M
- Turnover
- 65.07M
- Avg Price
- 20.621
- Bid/Ask Ratio
- --
- Amplitude
- 9.13%
- 52wk High
- 21.390
- Volume Ratio
- 2.10
- Turnover Ratio
- 3.37%
Fortrea Analyst Rating
View MoreForecast & Rating
Jul 29, 2026Price forecast
$18.53-9.18%
Forecast & RatingBuy
12analysts
- Strong buy41.67%
- Buy0.00%
- Hold41.67%
- Sell0.00%
- Strong sell16.67%
News
- Tip Ranks · 1 day ago, 05:58 AM
Fortrea Names Interim CFO Amid Ongoing Legal Dispute
- Quartr · 1 day ago, 05:36 AM
FTRE: Q2 2026 saw improved profitability, higher guidance, and strong new business momentum
- Unusual Whales · 1 day ago, 05:33 AM
Fortrea Reports Second Quarter 2026 Results
- Market Beat · Jul 21 at 12:06 AM
Fortrea (NASDAQ:FTRE) Downgraded by Wall Street Zen to Hold
- PUBT · Jul 15 at 04:27 PM
Fortrea CFO Jason F. Knoblauch files initial beneficial ownership statement
- PUBT · Jul 14 at 03:07 PM
Fortrea chief accounting officer Parks resigns; Russell named interim CAO
